An international team of researchers has utilized CRISPR/Cas9 gene editing to reverse Huntington’s disease (HD) pathology in a mouse model. The findings could open up new treatment avenues for HD and other inherited neurodegenerative diseases.
Restricted Content / Members Only
You cannot view this content because It is available to members only. Please Login or Register to view this area.